Literature DB >> 22393830

Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.

Hu-Xia Lv1, Zhen-Hai Zhang, Ayman Y Waddad, Jian-Ping Zhou.   

Abstract

The aim of this study was to improve the solubility, stability and bioavailability of amorphous atorvastatin calcium (AT) by complexing it with hydroxypropyl-beta-cyclodextrin. The formation of the inclusion complexation was identified by molecular modeling, phase solubility diagrams, differential scanning calorimetry and X-ray powder diffractometry. Orally Disintegrating Tablets (ODT) were then manufactured by direct compression. Apart from improved stability compared to pure AT, disintegration time of 27s, hardness of 5 kg and favorable mouth feel were achieved. In vitro dissolution tests of the ODT of AT inclusion complex exhibited higher dissolution rates than those with pure drug and the commercial tablet Lipitor. In vivo bioavailability studies in rats also showed shorter T(max), higher C(max) and increased AUC of 4.42 and 1.86 fold compared to the plain drug ODT and Lipitor. These results strongly suggest to use HP-beta-CD to improve the physicochemical characteristics and bioavailability of AT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22393830

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Atorvastatin calcium inclusion complexation with polysaccharide arabinogalactan and saponin disodium glycyrrhizate for increasing of solubility and bioavailability.

Authors:  Ruiping Kong; Xingyi Zhu; Elizaveta S Meteleva; Nikolay E Polyakov; Mikhail V Khvostov; Dmitry S Baev; Tatjana G Tolstikova; Alexander V Dushkin; Weike Su
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Enhancement of dissolution of atorvastatin through preparation of polymeric solid dispersions using supercritical fluid technology.

Authors:  Bashar Altaani; Rana Obaidat; Walaa Malkawi
Journal:  Res Pharm Sci       Date:  2020-05-11

3.  The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo.

Authors:  Zhenbao Li; Wenhui Tao; Dong Zhang; Chunnuan Wu; Binbin Song; Shang Wang; Tianyang Wang; Mingming Hu; Xiaohong Liu; Yongjun Wang; Yinghua Sun; Jin Sun
Journal:  Asian J Pharm Sci       Date:  2016-08-31       Impact factor: 6.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.